The 52nd annual meeting of the American Society of Hematology (ASH) was held in Orlando, FL from December 4 – 7, 2010. This report will highlight key data presentations of drugs under development as well as several approved drugs moving toward expanded labels.

Some of the drugs were featured in multiple presentations, and we have only highlighted the most significant presentations for each drug. Data events from trials covering multiple indications are only listed under a single indication.

A comprehensive list of 2010 ASH presentations are listed at the end of the report with links to their respective entries in BioMedTracker. Please see the actual BioMedTracker entries for more detailed information on each ASH event.

For the full report, please download the PDF version at the top of this page.

For our disclosures, please read the BioMedTracker Research Standards.